Chinese Traditional and Herbal Drugs
|
2025, 56(12): 4436-4452
Gut microbiota-P2X7R/NLRP3 signaling pathway crosstalk: Unveiling neuroinflammation and metabolic regulation mechanisms in depression and traditional Chinese medicine interventions
Full
LIU Zhiyuan1, ZOU Manshu1,2, HAN Yuanshan3, ZHAO Hongqing1,2, HE Haixia3, TANG Lin3, WANG Yuhong1,2
Affiliations
1 Hunan University of Traditional Chinese Medicine, Science and Technology Innovation Center, Changsha 410208, China;
2 Hunan Key Laboratory of Traditional Chinese Medicine Prevention and Treatment of Depressive Diseases, Changsha 410208, China;
3 Hunan University of Traditional Chinese Medicine, First Affiliated Hospital, Changsha 410007, China
doi: 10.7501/j.issn.0253-2670.2025.12.026
Outline
Recent studies have shown that the gut microbiota and P2X purinoceptor 7 receptor (P2X7R)/NOD-like receptor family pyrin domain-containing protein 3 (NLRP3) signaling pathway play critical roles in neuroinflammation and metabolic regulation in depression. This research focuses on the interaction between the gut microbiota and P2X7R/NLRP3 signaling pathway, systematically elucidating its potential role in depression-related neuroinflammation and metabolic regulation. Key findings include: the gut microbiota regulates immune and metabolic functions through their metabolites, thereby suppressing abnormal activation of P2X7R/NLRP3 signaling pathway and alleviating depressive-like behaviors, conversely, aberrant activation of this pathway exacerbates gut microbiota dysbiosis, thereby forming a vicious cycle of “microbiota-inflammation-metabolism”. Based on these findings, targeting “gut microbiota-P2X7R/NLRP3” axis has emerged as a promising therapeutic strategy. Notably, herbal medicine interventions—including bioactive monomers (e.g., cannabidiol, berberine, salidroside) and classical formulations (e.g., Huanglian Jiedu Decoction, Wuzhuyu Decoction)—demonstrate therapeutic efficacy through this signaling axis by mitigating neuroinflammatory cascades and restoring energy metabolism. This work innovatively establishes a bidirectional regulatory framework for “gut microbiota-P2X7R/NLRP3” axis in depression and proposes mechanism-guided therapeutic approaches, providing a critical theoretical foundation for advancing depression treatment strategies.
gut microbiota
/
P2X7R
/
NLRP3
/
depression
/
neuroinflammation
/
metabolic regulation
/
cannabidiol
/
berberine
/
salidroside
/
Huanglian Jiedu Decoction
/
Wuzhuyu Decoction
刘致远, 邹蔓姝, 韩远山, 赵洪庆, 贺海霞, 唐林, 王宇红.
肠道菌群-P2X7R/NLRP3信号通路互作:揭示抑郁症中的神经炎症与代谢调控机制及中药干预研究.
中草药,
2025
, 56
(12)
: 4436
-4452
.
DOI: 10.7501/j.issn.0253-2670.2025.12.026
LIU Zhiyuan, ZOU Manshu, HAN Yuanshan, ZHAO Hongqing, HE Haixia, TANG Lin, WANG Yuhong.
Gut microbiota-P2X7R/NLRP3 signaling pathway crosstalk: Unveiling neuroinflammation and metabolic regulation mechanisms in depression and traditional Chinese medicine interventions[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(12)
: 4436
-4452
.
DOI: 10.7501/j.issn.0253-2670.2025.12.026
Year 2025 volume 56 Issue 12
48
7
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.12.026
- Receive Date:2025-02-28
- Online Date:2026-11-13